Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
Giovanni Landoni, Alberto Zangrillo, Gioia Piersanti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10

Showing 10 citing articles:

Bidirectional causal associations between type 2 diabetes and COVID‐19
Hongbao Cao, Ancha Baranova, Xuejuan Wei, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 67
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
А. О. Шпаков
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6187-6187
Open Access | Times Cited: 26
Investigational pharmacological agents for the treatment of ARDS
Katyayini Aribindi, Michelle Lim, Satyan Lakshminrusimha, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 243-277
Closed Access | Times Cited: 9
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury
Guilherme Pasetto Fadanni, João Β. Calixto
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 13-25
Closed Access | Times Cited: 10
NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8
İrfan Baki Kılıç, Açelya Yaşar, İrem Yalım Camcı, et al.
Turkish Journal of Immunology (2024), pp. 127-135
Open Access | Times Cited: 1
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia
P Deschamps, Margaux Wacheux, Axel Gosseye, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 22
Open Access | Times Cited: 1
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Lorenzo Piemonti, Giovanni Landoni, Antonio Voza, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2437-2456
Open Access | Times Cited: 3
Reparixin improves survival in critically ill and transplant patients: A meta‐analysis
Gioia Piersanti, Giovanni Landoni, Tommaso Scquizzato, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 10
Open Access | Times Cited: 2
The Influence of COVID-19 in Endocrine Research: Critical Overview, Methodological Implications and a Guideline for Future Designs
Reza Rastmanesh, Lucky Krishnia, Manoj Kumar Kashyap
Clinical Medicine Insights Endocrinology and Diabetes (2023) Vol. 16
Open Access | Times Cited: 1
NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8
İrfan Baki Kılıç, Açelya Yaşar, İrem Yalım Camcı, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top